1. Home
  2. GSIT vs CMRX Comparison

GSIT vs CMRX Comparison

Compare GSIT & CMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSIT
  • CMRX
  • Stock Information
  • Founded
  • GSIT 1995
  • CMRX 2000
  • Country
  • GSIT United States
  • CMRX United States
  • Employees
  • GSIT N/A
  • CMRX N/A
  • Industry
  • GSIT Semiconductors
  • CMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GSIT Technology
  • CMRX Health Care
  • Exchange
  • GSIT Nasdaq
  • CMRX Nasdaq
  • Market Cap
  • GSIT 74.5M
  • CMRX 77.1M
  • IPO Year
  • GSIT N/A
  • CMRX 2013
  • Fundamental
  • Price
  • GSIT $3.20
  • CMRX $2.89
  • Analyst Decision
  • GSIT
  • CMRX Strong Buy
  • Analyst Count
  • GSIT 0
  • CMRX 2
  • Target Price
  • GSIT N/A
  • CMRX $8.50
  • AVG Volume (30 Days)
  • GSIT 135.1K
  • CMRX 11.2M
  • Earning Date
  • GSIT 01-23-2025
  • CMRX 11-07-2024
  • Dividend Yield
  • GSIT N/A
  • CMRX N/A
  • EPS Growth
  • GSIT N/A
  • CMRX N/A
  • EPS
  • GSIT N/A
  • CMRX N/A
  • Revenue
  • GSIT $19,691,000.00
  • CMRX $159,000.00
  • Revenue This Year
  • GSIT N/A
  • CMRX N/A
  • Revenue Next Year
  • GSIT N/A
  • CMRX $1,690.28
  • P/E Ratio
  • GSIT N/A
  • CMRX N/A
  • Revenue Growth
  • GSIT N/A
  • CMRX N/A
  • 52 Week Low
  • GSIT $1.88
  • CMRX $0.75
  • 52 Week High
  • GSIT $6.02
  • CMRX $3.39
  • Technical
  • Relative Strength Index (RSI)
  • GSIT 47.13
  • CMRX 84.35
  • Support Level
  • GSIT $2.54
  • CMRX $2.74
  • Resistance Level
  • GSIT $3.12
  • CMRX $3.02
  • Average True Range (ATR)
  • GSIT 0.16
  • CMRX 0.26
  • MACD
  • GSIT -0.01
  • CMRX 0.18
  • Stochastic Oscillator
  • GSIT 35.42
  • CMRX 77.13

About GSIT GSI Technology

GSI Technology Inc is a provider of semiconductor memory solutions. The company develops and markets high-performance memory products, including Very Fast static random access memory, or SRAM, that are incorporated in high-performance networking and telecommunications equipment, such as routers, switches, wide area network infrastructure equipment, wireless base stations, and network access equipment. It sells these products to original equipment manufacturers and customers including Nokia. In addition, it serves the ongoing needs of the military, aerospace, industrial, test and measurement equipment, and automotive and medical markets for high-performance SRAMs. It operates geographically in China, Singapore, the Netherlands, Germany, Rest of the world, and the United States.

About CMRX Chimerix Inc.

Chimerix Inc. is a biopharmaceutical company based in the United States that engages in the research, development, and commercialization of medicines. Its portfolio includes treatment for acute myeloid leukemia (or AML) and antiviral treatment for smallpox. The company generates revenue through revenue related to non-refundable upfront fees, royalties and milestone payments earned under license agreements, also by royalty revenue related to sales of TEMBEXA made by Emergent after the Asset Sale. The company operates only in one business segment namely pharmaceuticals.

Share on Social Networks: